초록 ▼

An ophthalmic drug delivery device having a first end and a second end, an injection port, a reservoir, and a sleeve is disclosed. The injection port is for sealingly engaging a needle of a syringe, which is for providing a fluid comprising a pharmaceutically active agent. The reservoir is disposed

An ophthalmic drug delivery device having a first end and a second end, an injection port, a reservoir, and a sleeve is disclosed. The injection port is for sealingly engaging a needle of a syringe, which is for providing a fluid comprising a pharmaceutically active agent. The reservoir is disposed within the device, is fluidly coupled to the injection port, and has an opening for communicating the fluid to an outer surface of a sclera of an eye. The sleeve is for engaging the device proximate overlapping portions of the first end and the second end for forming a generally ring-shaped three-dimensional geometry upon implantation of the device on the outer surface of the sclera. The device is useful for the treatment of a disease of the posterior segment of the eye.

대표청구항 ▼

What is claimed is: 1. An ophthalmic drug delivery device, comprising: a first end and a second end; an injection port for sealingly engaging a needle of a syringe, said syringe for providing a fluid comprising a pharmaceutically active agent; a reservoir disposed within said device, fluidly couple

What is claimed is: 1. An ophthalmic drug delivery device, comprising: a first end and a second end; an injection port for sealingly engaging a needle of a syringe, said syringe for providing a fluid comprising a pharmaceutically active agent; a reservoir disposed within said device, fluidly coupled to said injection port, and having an opening for communicating said fluid to an outer surface of a sclera of an eye; and a sleeve for engaging said device proximate overlapping portions of said first end and said second end for forming a generally ring-shaped three-dimensional geometry upon implantation of said device on said outer surface of said sclera. 2. The ophthalmic drug delivery device of claim 1 further comprising an anterior side, and wherein said injection port is disposed on said anterior side. 3. The ophthalmic drug delivery device of claim 1 further comprising a posterior side, and wherein said posterior side comprises a sharp exterior surface for piercing connective tissue that may encapsulate said device upon implantation on said outer surface of said sclera. 4. The ophthalmic drug delivery device of claim 1 wherein said reservoir comprises a plurality of said openings for communicating said fluid to said outer surface of said sclera. 5. The ophthalmic drug delivery device of claim 1 wherein said device delivers said pharmaceutically active agent through said sclera and a choroid into a retina of said eye. 6. The ophthalmic drug delivery device of claim 5 wherein said device delivers said pharmaceutically active agent to substantially all of said retina. 7. The ophthalmic drug delivery device of claim 5 wherein said device delivers said pharmaceutically active agent to a portion of said retina proximate said device.